Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Section Content Menu
Skip to Common Links
Enter Search terms
A-Z Index
Home
Food
Drugs
Medical Devices
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Radiation-Emitting Products
Tobacco Products
-
Drugs
Share
Home
>
Drugs
>
Guidance, Compliance & Regulatory Information
>
Guidances (Drugs)
Section Contents Menu
Guidance, Compliance & Regulatory Information
Guidances (Drugs)
Advertising
Biopharmaceutics
CMC - Microbiology (Chemistry, Manufacturing, and Controls)
Chemistry, Manufacturing, and Controls (CMC)
Clinical / Antimicrobial
Clinical / Medical
Clinical Pharmacology
Combination Products
Concept Papers
Current Good Manufacturing Practices (CGMPs)/Compliance
Drug Safety
Electronic Submissions
FDAAA (Food and Drug Administration Amendments Act)
Generics
Good Review Practices
Individual Product Bioequivalence Recommendations
Industry Letters
International Conference on Harmonisation - Efficacy
International Conference on Harmonisation - Joint Safety/Efficacy (Multidisciplinary)
International Conference on Harmonisation - Quality
International Conference on Harmonisation - Safety
Investigational New Drug Applications
Labeling
Microbiology
Modernization Act
Over-the-Counter
Pharm / Tox
Procedural
Small Entity Compliance Guides
User Fees
-
Advertising
Title and Format
Type
Issue Date
Accelerated Approval Products: Submission of Promotional Materials (PDF - 17 KB)
Draft
3/26/1999
Aerosol Steroid Product Safety Information in Prescription Drug Advertising and Promotional Labeling (PDF - 84 KB)
Final
12/1997
Brief Summary: Disclosing Risk Information in Consumer-Directed Print Advertisements (PDF - 192 KB)
Labeling Example (PDF - 105 KB)
Labeling Example; Consumer-Friendly Version (PDF - 95KB)
Draft
2/4/2004
Consumer-Directed Broadcast Advertisements (PDF - 36KB)
Questions and Answers (PDF - 83 KB)
Final
8/1999
Consumer-Directed Broadcast Advertising of Restricted Devices (PDF - 41 KB)
Draft
1/26/2004
“Help-Seeking” and Other Disease Awareness Communications by or on Behalf of Drug and Device Firms (PDF - 188 KB)
Draft
1/26/2004
Industry-Supported Scientific and Educational Activities (PDF - 429 KB)
Final
12/3/1997
Presenting Risk Information in Prescription Drug and Medical Device Promotion (PDF - 387 KB)
Draft
5/26/2009
Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling (PDF - 86KB)
Draft
1/1999
-
-
-
-
-